Clinical Outcomes and Breast Cancer Subtypes in Patients with Brain Metastases
Hyuk-Chan Kwon(Korea Research Institute of Standards and Science), Hyojin Kim(Seoul National University), Miri Lee(University Medical Center), Hyung‐Sik Lee(University Medical Center), Dae Cheol Kim(Taiwan Livestock Research Institute), Sung Yong Oh(Korea University Medical Center), Suee Lee(Dong-A University), Sung‐Hyun Kim(Dong-A University), Yang Soo Kim(Kyoto University), Young Jin Choi(Pusan National University Hospital), Kyung A Kwon(Dong-A University), Jin Hwa Lee(Brigham and Women's Hospital), Se Heon Cho(Dong-A University), Goon-Jae Cho(Pusan National University Hospital)
Cited by 17
Related Papers
Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial
|The Lancet Oncology|2008|522
ARTIST 2: Interim results of a phase III trial involving adjuvant chemotherapy and/or chemoradiotherapy after D2-gastrectomy in stage II/III gastric cancer (GC).
|Journal of Clinical Oncology|2019|79
Absolute quantitation of DNA methylation of 28 candidate genes in prostate cancer using pyrosequencing.
|PubMed|2011|77